Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study

J Lette, JL Tatum, S Fraser, DD Miller… - Journal of Nuclear …, 1995 - Springer
Background Dipyridamole imaging is widely used as an alternative to exercise testing to
identify and risk stratify patients with coronary artery disease. Safety data on intravenous …

[BOOK][B] Meyler's side effects of cardiovascular drugs

JK Aronson - 2009 - books.google.com
Elsevier now offers a series of derivative works based on the acclaimed Meylers Side Effect
of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the …

The safety of carotid stenosis during vasodilator pharmacologic stress testing

W Perucki, A Becerra, O Blazek, A Shaik… - Journal of Nuclear …, 2023 - Elsevier
Background While thousands of patients undergo stress testing annually, the risk of exercise
and pharmacologic stress in patients with carotid artery disease has not been fully defined …

Effect of intravenous dipyridamole on cerebral blood flow in humans: a PET study

H Ito, T Kinoshita, Y Tamura, I Yokoyama, H Iida - Stroke, 1999 - Am Heart Assoc
Background and Purpose—Dipyridamole increases the concentration of circulating
adenosine, which is a potent vasodilator, by inhibition of uptake of adenosine into the …

Dipyridamole-thallium versus dobutamine echocardiographic stress testing: a clinician's viewpoint

JP Johns, SA Abraham, KA Eagle - American Heart Journal, 1995 - Elsevier
Pharmacologic stress testing of patients with suspected or proven coronary artery disease
has achieved acceptance as a means of evaluating patients who are unable to perform …

Vasodilatory effect of adenosine triphosphate does not change cerebral blood flow: a PET study with 15O-water

R Hussain, T Tsuchida, T Kudo, M Kobayashi… - Annals of nuclear …, 2009 - Springer
Objective Adenosine triphosphate (ATP) is the parent compound of adenosine and well
known as a powerful vasodilator. To investigate the effect of ATP on cerebral blood flow …

Safety of dipyridamole testing in patients with cerebrovascular disease

J Lette, G Carini, JL Tatum, N Paquet, G Bisson… - The American journal of …, 1995 - Elsevier
Safety of Dipyridamole Testing in Patients With Cerebrovascular Dwease Page 1 ography.
Although WC speculate that early identification of leaflet avulsions and subsequent early …

[HTML][HTML] Cerebrovascular steal phenomenon in a patient undergoing dipyridamole nuclear perfusion cardiac imaging

M Raju, G Mood, H Laird-Fick, DO Shah… - Journal of Cardiology …, 2012 - Elsevier
Transient ischemic neurological deficits following intravenous dipyridamole administration
during pharmacological cardiac stress test are seldom reported, but there can be serious …

Comparison between Acetazolamide and Dipyridamole Activated SPECT for Cerebral Vascular Reserve Capacity Measurement.

SB Ban, JG Moon, SK Bae, HG Lee, BC Jeon… - Journal of Korean …, 1999 - jkns.or.kr
Object of this study was to make comparison between acetazolamide and dipyridamole
activated SPECT for measurement of cerebral vascular reserve capacity. This study was …

同位素鉈^(201) 心肌灌注造影時靜脈注射 Dipyridamole 引發可逆性神經學併發症一病例報告

周伯翰, 張博淵 - 北市醫學雜誌, 2016 - airitilibrary.com
同位素鉈^(201)-心肌灌注造影(Thallium^(201) Myocardial Perfusion Imaging)
在評估心肌缺氧之嚴重度及診斷冠狀動脈疾病佔有重要角色. 因身體狀況不佳而無法施行運動 …